Plaquenil, also known as hydroxychloroquine, has been a topic of interest in recent years, particularly due to its potential use in treating certain viral infections. However, it's important to note that its primary use remains the treatment of malaria, lupus, and rheumatoid arthritis. One of the potential side effects of long-term Plaquenil use is retinal toxicity, which can lead to vision loss. Therefore, regular eye exams are crucial for patients taking this medication. Let's delve into the Plaquenil eye exam guidelines for 2022.

These guidelines, set by the American Academy of Ophthalmology, aim to ensure the earliest possible detection of retinal toxicity, allowing for timely intervention and prevention of vision loss.

Initial Eye Exam and Baseline Testing
Before starting Plaquenil, patients should undergo a comprehensive eye exam to establish a baseline for their vision and retinal health.

This initial exam should include:
- Best-corrected visual acuity
- Color vision testing
- Fundus photography or optical coherence tomography (OCT)
- Automated visual field testing

Frequency of Follow-up Exams
After the baseline exam, follow-up exams are essential to monitor for any signs of retinal toxicity.
According to the 2022 guidelines, the frequency of these exams is as follows:

- Every 6 months for the first year of treatment
- Annually thereafter, provided there are no signs of toxicity
Exam Components in Follow-up Appointments
During follow-up exams, the following tests should be performed:

Best-corrected visual acuity and color vision testing should be repeated at each visit. Fundus photography or OCT should be done annually, and automated visual field testing should be performed every 1-2 years, depending on the patient's risk factors and the ophthalmologist's discretion.
Risk Factors and Special Considerations




















Certain factors can increase the risk of Plaquenil retinal toxicity. These include:
Long-term use of high doses, age over 60, renal impairment, and pre-existing retinal disease. Patients with these risk factors may need more frequent eye exams.
When to Discontinue Plaquenil
If retinal toxicity is detected, Plaquenil should be discontinued immediately. The decision to restart the medication should be made in consultation with the prescribing physician and the ophthalmologist, considering the patient's underlying condition and the risk of retinal toxicity.
In conclusion, regular eye exams are non-negotiable for patients taking Plaquenil. These exams are not just about meeting guidelines; they are about preserving vision. If you or a loved one is taking Plaquenil, it's crucial to stay on top of these eye exam guidelines. Don't wait, schedule your next eye exam today.